Physician profile
Kunal Gupta
NPI 1023256567
$8,939.84
in general payments reported to CMS, 2019-2025
32 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,431 · 2020: $856 · 2021: $1,116 · 2022: $913 · 2023: $939 · 2024: $1,354 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00 · Grant: $20.00 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,574.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
| Grant | $20.00 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,200.83 | 2019-2025 | Exalt Model D, Spyglass, Spyglass |
| Abbvie INC. | $921.17 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $612.33 | 2019-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $431.71 | 2019-2025 | Stelara, Tremfya, Simponi |
| Pfizer INC. | $376.27 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $360.94 | 2019-2025 | Entyvio |
| Qol Medical, LLC | $356.67 | 2021-2025 | Sucraid, Sucraid |
| Ethicon US, LLC | $250.01 | 2021-2024 | Vistaseal, Echelon; Endopath, Harmonic |
| Madrigal Pharmaceuticals | $234.39 | 2024-2025 | Rezdiffra, Resmetirom |
| Genzyme Corporation | $175.26 | 2023-2025 | |
| Stryker Corporation | $115.26 | 2024 | 1788 |
| Covidien Lp | $114.47 | 2019 | |
| Braintree Laboratories, INC. | $108.21 | 2021-2025 | Suflave, Sutab |
| Laborie Medical Technologies Corp. | $90.45 | 2024 | |
| Ferring Pharmaceuticals INC. | $79.83 | 2019-2023 | Cimzia, Rebyota |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $76.38 | 2022-2024 | Zeposia |
| Aimmune Therapeutics, INC. | $65.11 | 2024-2025 | Zenpep, Vowst |
| Janssen Pharmaceuticals, INC | $40.41 | 2021 | |
| Novo Nordisk INC | $35.64 | 2025 | Wegovy |
| Mindray Ds USA, INC. | $34.31 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $33.07 | 2025 | Iqirvo |
| Alfasigma USA, INC. | $30.84 | 2020 | |
| Phathom Pharmaceuticals, INC. | $29.64 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $27.83 | 2020-2021 | |
| Shionogi INC | $25.62 | 2019 | |
| Lilly USA, LLC | $24.23 | 2024 | Omvoh |
| Ardelyx, INC. | $18.87 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $15.14 | 2019 | |
| Daiichi Sankyo INC. | $14.82 | 2019 | |
| Beigene USA, INC. | $14.00 | 2022 | |
| Redhill Biopharma INC. | $13.88 | 2020 | |
| Intercept Pharmaceuticals, INC. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.